Global mRNA Vaccine Raw Materials Market Growth (Status and Outlook) 2026-2032
The global mRNA Vaccine Raw Materials market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The development and production of mRNA vaccines is relatively simple, scalable, and extremely rapid. mRNA is produced in vitro through an enzymatic process without the need to remove cells or host cell proteins. This simplified production process allows GMP facilities to be converted to produce new protein targets in a very short period of time, with only minimal changes to the process and formulation.
United States market for mRNA Vaccine Raw Materials is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for mRNA Vaccine Raw Materials is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for mRNA Vaccine Raw Materials is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key mRNA Vaccine Raw Materials players cover Thermo Fisher Scientific Inc., Danaher Corporation, Kaneka Eurogentec S.A., BioSpring, GenScript, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?mRNA Vaccine Raw Materials Industry Forecast? looks at past sales and reviews total world mRNA Vaccine Raw Materials sales in 2025, providing a comprehensive analysis by region and market sector of projected mRNA Vaccine Raw Materials sales for 2026 through 2032. With mRNA Vaccine Raw Materials sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Vaccine Raw Materials industry.
This Insight Report provides a comprehensive analysis of the global mRNA Vaccine Raw Materials landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on mRNA Vaccine Raw Materials portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global mRNA Vaccine Raw Materials market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Vaccine Raw Materials and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Vaccine Raw Materials.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccine Raw Materials market by product type, application, key players and key regions and countries.
Segmentation by Type:
The development and production of mRNA vaccines is relatively simple, scalable, and extremely rapid. mRNA is produced in vitro through an enzymatic process without the need to remove cells or host cell proteins. This simplified production process allows GMP facilities to be converted to produce new protein targets in a very short period of time, with only minimal changes to the process and formulation.
United States market for mRNA Vaccine Raw Materials is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for mRNA Vaccine Raw Materials is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for mRNA Vaccine Raw Materials is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key mRNA Vaccine Raw Materials players cover Thermo Fisher Scientific Inc., Danaher Corporation, Kaneka Eurogentec S.A., BioSpring, GenScript, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?mRNA Vaccine Raw Materials Industry Forecast? looks at past sales and reviews total world mRNA Vaccine Raw Materials sales in 2025, providing a comprehensive analysis by region and market sector of projected mRNA Vaccine Raw Materials sales for 2026 through 2032. With mRNA Vaccine Raw Materials sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Vaccine Raw Materials industry.
This Insight Report provides a comprehensive analysis of the global mRNA Vaccine Raw Materials landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on mRNA Vaccine Raw Materials portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global mRNA Vaccine Raw Materials market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Vaccine Raw Materials and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Vaccine Raw Materials.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccine Raw Materials market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Plasmid DNA (pDNA)
- Enzyme
- Other
- (non-replicating) mRNA vaccine
- (self-amplifying) mRNA vaccine
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Kaneka Eurogentec S.A.
- BioSpring
- GenScript
- Aji Bio-Pharma
- Merck KGaA
- Aldevron
- Hongene
- WuXi Biologics
- Asymchem
- Cosychem
- Novoprotein
- Vazyme
- Yeasen
- KACTUS
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Vaccine Raw Materials Market Size (2021-2032)
2.1.2 mRNA Vaccine Raw Materials Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for mRNA Vaccine Raw Materials by Country/Region (2021, 2025 & 2032)
2.2 mRNA Vaccine Raw Materials Segment by Type
2.2.1 Plasmid DNA (pDNA)
2.2.2 Enzyme
2.2.3 Other
2.2.4 mRNA Vaccine Raw Materials Market Size by Type
2.2.4.1 mRNA Vaccine Raw Materials Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global mRNA Vaccine Raw Materials Market Size Market Share by Type (2021-2026)
2.3 mRNA Vaccine Raw Materials Segment by Application
2.3.1 (non-replicating) mRNA vaccine
2.3.2 (self-amplifying) mRNA vaccine
2.3.3 mRNA Vaccine Raw Materials Market Size by Application
2.3.3.1 mRNA Vaccine Raw Materials Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global mRNA Vaccine Raw Materials Market Size Market Share by Application (2021-2026)
3 MRNA VACCINE RAW MATERIALS MARKET SIZE BY PLAYER
3.1 mRNA Vaccine Raw Materials Market Size Market Share by Player
3.1.1 Global mRNA Vaccine Raw Materials Revenue by Player (2021-2026)
3.1.2 Global mRNA Vaccine Raw Materials Revenue Market Share by Player (2021-2026)
3.2 Global mRNA Vaccine Raw Materials Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MRNA VACCINE RAW MATERIALS BY REGION
4.1 mRNA Vaccine Raw Materials Market Size by Region (2021-2026)
4.2 Global mRNA Vaccine Raw Materials Annual Revenue by Country/Region (2021-2026)
4.3 Americas mRNA Vaccine Raw Materials Market Size Growth (2021-2026)
4.4 APAC mRNA Vaccine Raw Materials Market Size Growth (2021-2026)
4.5 Europe mRNA Vaccine Raw Materials Market Size Growth (2021-2026)
4.6 Middle East & Africa mRNA Vaccine Raw Materials Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas mRNA Vaccine Raw Materials Market Size by Country (2021-2026)
5.2 Americas mRNA Vaccine Raw Materials Market Size by Type (2021-2026)
5.3 Americas mRNA Vaccine Raw Materials Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Vaccine Raw Materials Market Size by Region (2021-2026)
6.2 APAC mRNA Vaccine Raw Materials Market Size by Type (2021-2026)
6.3 APAC mRNA Vaccine Raw Materials Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe mRNA Vaccine Raw Materials Market Size by Country (2021-2026)
7.2 Europe mRNA Vaccine Raw Materials Market Size by Type (2021-2026)
7.3 Europe mRNA Vaccine Raw Materials Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Vaccine Raw Materials by Region (2021-2026)
8.2 Middle East & Africa mRNA Vaccine Raw Materials Market Size by Type (2021-2026)
8.3 Middle East & Africa mRNA Vaccine Raw Materials Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MRNA VACCINE RAW MATERIALS MARKET FORECAST
10.1 Global mRNA Vaccine Raw Materials Forecast by Region (2027-2032)
10.1.1 Global mRNA Vaccine Raw Materials Forecast by Region (2027-2032)
10.1.2 Americas mRNA Vaccine Raw Materials Forecast
10.1.3 APAC mRNA Vaccine Raw Materials Forecast
10.1.4 Europe mRNA Vaccine Raw Materials Forecast
10.1.5 Middle East & Africa mRNA Vaccine Raw Materials Forecast
10.2 Americas mRNA Vaccine Raw Materials Forecast by Country (2027-2032)
10.2.1 United States Market mRNA Vaccine Raw Materials Forecast
10.2.2 Canada Market mRNA Vaccine Raw Materials Forecast
10.2.3 Mexico Market mRNA Vaccine Raw Materials Forecast
10.2.4 Brazil Market mRNA Vaccine Raw Materials Forecast
10.3 APAC mRNA Vaccine Raw Materials Forecast by Region (2027-2032)
10.3.1 China mRNA Vaccine Raw Materials Market Forecast
10.3.2 Japan Market mRNA Vaccine Raw Materials Forecast
10.3.3 Korea Market mRNA Vaccine Raw Materials Forecast
10.3.4 Southeast Asia Market mRNA Vaccine Raw Materials Forecast
10.3.5 India Market mRNA Vaccine Raw Materials Forecast
10.3.6 Australia Market mRNA Vaccine Raw Materials Forecast
10.4 Europe mRNA Vaccine Raw Materials Forecast by Country (2027-2032)
10.4.1 Germany Market mRNA Vaccine Raw Materials Forecast
10.4.2 France Market mRNA Vaccine Raw Materials Forecast
10.4.3 UK Market mRNA Vaccine Raw Materials Forecast
10.4.4 Italy Market mRNA Vaccine Raw Materials Forecast
10.4.5 Russia Market mRNA Vaccine Raw Materials Forecast
10.5 Middle East & Africa mRNA Vaccine Raw Materials Forecast by Region (2027-2032)
10.5.1 Egypt Market mRNA Vaccine Raw Materials Forecast
10.5.2 South Africa Market mRNA Vaccine Raw Materials Forecast
10.5.3 Israel Market mRNA Vaccine Raw Materials Forecast
10.5.4 Turkey Market mRNA Vaccine Raw Materials Forecast
10.6 Global mRNA Vaccine Raw Materials Forecast by Type (2027-2032)
10.7 Global mRNA Vaccine Raw Materials Forecast by Application (2027-2032)
10.7.1 GCC Countries Market mRNA Vaccine Raw Materials Forecast
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Information
11.1.2 Thermo Fisher Scientific Inc. mRNA Vaccine Raw Materials Product Offered
11.1.3 Thermo Fisher Scientific Inc. mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Thermo Fisher Scientific Inc. Main Business Overview
11.1.5 Thermo Fisher Scientific Inc. Latest Developments
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Information
11.2.2 Danaher Corporation mRNA Vaccine Raw Materials Product Offered
11.2.3 Danaher Corporation mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Danaher Corporation Main Business Overview
11.2.5 Danaher Corporation Latest Developments
11.3 Kaneka Eurogentec S.A.
11.3.1 Kaneka Eurogentec S.A. Company Information
11.3.2 Kaneka Eurogentec S.A. mRNA Vaccine Raw Materials Product Offered
11.3.3 Kaneka Eurogentec S.A. mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Kaneka Eurogentec S.A. Main Business Overview
11.3.5 Kaneka Eurogentec S.A. Latest Developments
11.4 BioSpring
11.4.1 BioSpring Company Information
11.4.2 BioSpring mRNA Vaccine Raw Materials Product Offered
11.4.3 BioSpring mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 BioSpring Main Business Overview
11.4.5 BioSpring Latest Developments
11.5 GenScript
11.5.1 GenScript Company Information
11.5.2 GenScript mRNA Vaccine Raw Materials Product Offered
11.5.3 GenScript mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 GenScript Main Business Overview
11.5.5 GenScript Latest Developments
11.6 Aji Bio-Pharma
11.6.1 Aji Bio-Pharma Company Information
11.6.2 Aji Bio-Pharma mRNA Vaccine Raw Materials Product Offered
11.6.3 Aji Bio-Pharma mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Aji Bio-Pharma Main Business Overview
11.6.5 Aji Bio-Pharma Latest Developments
11.7 Merck KGaA
11.7.1 Merck KGaA Company Information
11.7.2 Merck KGaA mRNA Vaccine Raw Materials Product Offered
11.7.3 Merck KGaA mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Merck KGaA Main Business Overview
11.7.5 Merck KGaA Latest Developments
11.8 Aldevron
11.8.1 Aldevron Company Information
11.8.2 Aldevron mRNA Vaccine Raw Materials Product Offered
11.8.3 Aldevron mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Aldevron Main Business Overview
11.8.5 Aldevron Latest Developments
11.9 Hongene
11.9.1 Hongene Company Information
11.9.2 Hongene mRNA Vaccine Raw Materials Product Offered
11.9.3 Hongene mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Hongene Main Business Overview
11.9.5 Hongene Latest Developments
11.10 WuXi Biologics
11.10.1 WuXi Biologics Company Information
11.10.2 WuXi Biologics mRNA Vaccine Raw Materials Product Offered
11.10.3 WuXi Biologics mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 WuXi Biologics Main Business Overview
11.10.5 WuXi Biologics Latest Developments
11.11 Asymchem
11.11.1 Asymchem Company Information
11.11.2 Asymchem mRNA Vaccine Raw Materials Product Offered
11.11.3 Asymchem mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Asymchem Main Business Overview
11.11.5 Asymchem Latest Developments
11.12 Cosychem
11.12.1 Cosychem Company Information
11.12.2 Cosychem mRNA Vaccine Raw Materials Product Offered
11.12.3 Cosychem mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Cosychem Main Business Overview
11.12.5 Cosychem Latest Developments
11.13 Novoprotein
11.13.1 Novoprotein Company Information
11.13.2 Novoprotein mRNA Vaccine Raw Materials Product Offered
11.13.3 Novoprotein mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Novoprotein Main Business Overview
11.13.5 Novoprotein Latest Developments
11.14 Vazyme
11.14.1 Vazyme Company Information
11.14.2 Vazyme mRNA Vaccine Raw Materials Product Offered
11.14.3 Vazyme mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Vazyme Main Business Overview
11.14.5 Vazyme Latest Developments
11.15 Yeasen
11.15.1 Yeasen Company Information
11.15.2 Yeasen mRNA Vaccine Raw Materials Product Offered
11.15.3 Yeasen mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Yeasen Main Business Overview
11.15.5 Yeasen Latest Developments
11.16 KACTUS
11.16.1 KACTUS Company Information
11.16.2 KACTUS mRNA Vaccine Raw Materials Product Offered
11.16.3 KACTUS mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 KACTUS Main Business Overview
11.16.5 KACTUS Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Vaccine Raw Materials Market Size (2021-2032)
2.1.2 mRNA Vaccine Raw Materials Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for mRNA Vaccine Raw Materials by Country/Region (2021, 2025 & 2032)
2.2 mRNA Vaccine Raw Materials Segment by Type
2.2.1 Plasmid DNA (pDNA)
2.2.2 Enzyme
2.2.3 Other
2.2.4 mRNA Vaccine Raw Materials Market Size by Type
2.2.4.1 mRNA Vaccine Raw Materials Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global mRNA Vaccine Raw Materials Market Size Market Share by Type (2021-2026)
2.3 mRNA Vaccine Raw Materials Segment by Application
2.3.1 (non-replicating) mRNA vaccine
2.3.2 (self-amplifying) mRNA vaccine
2.3.3 mRNA Vaccine Raw Materials Market Size by Application
2.3.3.1 mRNA Vaccine Raw Materials Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global mRNA Vaccine Raw Materials Market Size Market Share by Application (2021-2026)
3 MRNA VACCINE RAW MATERIALS MARKET SIZE BY PLAYER
3.1 mRNA Vaccine Raw Materials Market Size Market Share by Player
3.1.1 Global mRNA Vaccine Raw Materials Revenue by Player (2021-2026)
3.1.2 Global mRNA Vaccine Raw Materials Revenue Market Share by Player (2021-2026)
3.2 Global mRNA Vaccine Raw Materials Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MRNA VACCINE RAW MATERIALS BY REGION
4.1 mRNA Vaccine Raw Materials Market Size by Region (2021-2026)
4.2 Global mRNA Vaccine Raw Materials Annual Revenue by Country/Region (2021-2026)
4.3 Americas mRNA Vaccine Raw Materials Market Size Growth (2021-2026)
4.4 APAC mRNA Vaccine Raw Materials Market Size Growth (2021-2026)
4.5 Europe mRNA Vaccine Raw Materials Market Size Growth (2021-2026)
4.6 Middle East & Africa mRNA Vaccine Raw Materials Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas mRNA Vaccine Raw Materials Market Size by Country (2021-2026)
5.2 Americas mRNA Vaccine Raw Materials Market Size by Type (2021-2026)
5.3 Americas mRNA Vaccine Raw Materials Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Vaccine Raw Materials Market Size by Region (2021-2026)
6.2 APAC mRNA Vaccine Raw Materials Market Size by Type (2021-2026)
6.3 APAC mRNA Vaccine Raw Materials Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe mRNA Vaccine Raw Materials Market Size by Country (2021-2026)
7.2 Europe mRNA Vaccine Raw Materials Market Size by Type (2021-2026)
7.3 Europe mRNA Vaccine Raw Materials Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Vaccine Raw Materials by Region (2021-2026)
8.2 Middle East & Africa mRNA Vaccine Raw Materials Market Size by Type (2021-2026)
8.3 Middle East & Africa mRNA Vaccine Raw Materials Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MRNA VACCINE RAW MATERIALS MARKET FORECAST
10.1 Global mRNA Vaccine Raw Materials Forecast by Region (2027-2032)
10.1.1 Global mRNA Vaccine Raw Materials Forecast by Region (2027-2032)
10.1.2 Americas mRNA Vaccine Raw Materials Forecast
10.1.3 APAC mRNA Vaccine Raw Materials Forecast
10.1.4 Europe mRNA Vaccine Raw Materials Forecast
10.1.5 Middle East & Africa mRNA Vaccine Raw Materials Forecast
10.2 Americas mRNA Vaccine Raw Materials Forecast by Country (2027-2032)
10.2.1 United States Market mRNA Vaccine Raw Materials Forecast
10.2.2 Canada Market mRNA Vaccine Raw Materials Forecast
10.2.3 Mexico Market mRNA Vaccine Raw Materials Forecast
10.2.4 Brazil Market mRNA Vaccine Raw Materials Forecast
10.3 APAC mRNA Vaccine Raw Materials Forecast by Region (2027-2032)
10.3.1 China mRNA Vaccine Raw Materials Market Forecast
10.3.2 Japan Market mRNA Vaccine Raw Materials Forecast
10.3.3 Korea Market mRNA Vaccine Raw Materials Forecast
10.3.4 Southeast Asia Market mRNA Vaccine Raw Materials Forecast
10.3.5 India Market mRNA Vaccine Raw Materials Forecast
10.3.6 Australia Market mRNA Vaccine Raw Materials Forecast
10.4 Europe mRNA Vaccine Raw Materials Forecast by Country (2027-2032)
10.4.1 Germany Market mRNA Vaccine Raw Materials Forecast
10.4.2 France Market mRNA Vaccine Raw Materials Forecast
10.4.3 UK Market mRNA Vaccine Raw Materials Forecast
10.4.4 Italy Market mRNA Vaccine Raw Materials Forecast
10.4.5 Russia Market mRNA Vaccine Raw Materials Forecast
10.5 Middle East & Africa mRNA Vaccine Raw Materials Forecast by Region (2027-2032)
10.5.1 Egypt Market mRNA Vaccine Raw Materials Forecast
10.5.2 South Africa Market mRNA Vaccine Raw Materials Forecast
10.5.3 Israel Market mRNA Vaccine Raw Materials Forecast
10.5.4 Turkey Market mRNA Vaccine Raw Materials Forecast
10.6 Global mRNA Vaccine Raw Materials Forecast by Type (2027-2032)
10.7 Global mRNA Vaccine Raw Materials Forecast by Application (2027-2032)
10.7.1 GCC Countries Market mRNA Vaccine Raw Materials Forecast
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Information
11.1.2 Thermo Fisher Scientific Inc. mRNA Vaccine Raw Materials Product Offered
11.1.3 Thermo Fisher Scientific Inc. mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Thermo Fisher Scientific Inc. Main Business Overview
11.1.5 Thermo Fisher Scientific Inc. Latest Developments
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Information
11.2.2 Danaher Corporation mRNA Vaccine Raw Materials Product Offered
11.2.3 Danaher Corporation mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Danaher Corporation Main Business Overview
11.2.5 Danaher Corporation Latest Developments
11.3 Kaneka Eurogentec S.A.
11.3.1 Kaneka Eurogentec S.A. Company Information
11.3.2 Kaneka Eurogentec S.A. mRNA Vaccine Raw Materials Product Offered
11.3.3 Kaneka Eurogentec S.A. mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Kaneka Eurogentec S.A. Main Business Overview
11.3.5 Kaneka Eurogentec S.A. Latest Developments
11.4 BioSpring
11.4.1 BioSpring Company Information
11.4.2 BioSpring mRNA Vaccine Raw Materials Product Offered
11.4.3 BioSpring mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 BioSpring Main Business Overview
11.4.5 BioSpring Latest Developments
11.5 GenScript
11.5.1 GenScript Company Information
11.5.2 GenScript mRNA Vaccine Raw Materials Product Offered
11.5.3 GenScript mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 GenScript Main Business Overview
11.5.5 GenScript Latest Developments
11.6 Aji Bio-Pharma
11.6.1 Aji Bio-Pharma Company Information
11.6.2 Aji Bio-Pharma mRNA Vaccine Raw Materials Product Offered
11.6.3 Aji Bio-Pharma mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Aji Bio-Pharma Main Business Overview
11.6.5 Aji Bio-Pharma Latest Developments
11.7 Merck KGaA
11.7.1 Merck KGaA Company Information
11.7.2 Merck KGaA mRNA Vaccine Raw Materials Product Offered
11.7.3 Merck KGaA mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Merck KGaA Main Business Overview
11.7.5 Merck KGaA Latest Developments
11.8 Aldevron
11.8.1 Aldevron Company Information
11.8.2 Aldevron mRNA Vaccine Raw Materials Product Offered
11.8.3 Aldevron mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Aldevron Main Business Overview
11.8.5 Aldevron Latest Developments
11.9 Hongene
11.9.1 Hongene Company Information
11.9.2 Hongene mRNA Vaccine Raw Materials Product Offered
11.9.3 Hongene mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Hongene Main Business Overview
11.9.5 Hongene Latest Developments
11.10 WuXi Biologics
11.10.1 WuXi Biologics Company Information
11.10.2 WuXi Biologics mRNA Vaccine Raw Materials Product Offered
11.10.3 WuXi Biologics mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 WuXi Biologics Main Business Overview
11.10.5 WuXi Biologics Latest Developments
11.11 Asymchem
11.11.1 Asymchem Company Information
11.11.2 Asymchem mRNA Vaccine Raw Materials Product Offered
11.11.3 Asymchem mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Asymchem Main Business Overview
11.11.5 Asymchem Latest Developments
11.12 Cosychem
11.12.1 Cosychem Company Information
11.12.2 Cosychem mRNA Vaccine Raw Materials Product Offered
11.12.3 Cosychem mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Cosychem Main Business Overview
11.12.5 Cosychem Latest Developments
11.13 Novoprotein
11.13.1 Novoprotein Company Information
11.13.2 Novoprotein mRNA Vaccine Raw Materials Product Offered
11.13.3 Novoprotein mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Novoprotein Main Business Overview
11.13.5 Novoprotein Latest Developments
11.14 Vazyme
11.14.1 Vazyme Company Information
11.14.2 Vazyme mRNA Vaccine Raw Materials Product Offered
11.14.3 Vazyme mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Vazyme Main Business Overview
11.14.5 Vazyme Latest Developments
11.15 Yeasen
11.15.1 Yeasen Company Information
11.15.2 Yeasen mRNA Vaccine Raw Materials Product Offered
11.15.3 Yeasen mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Yeasen Main Business Overview
11.15.5 Yeasen Latest Developments
11.16 KACTUS
11.16.1 KACTUS Company Information
11.16.2 KACTUS mRNA Vaccine Raw Materials Product Offered
11.16.3 KACTUS mRNA Vaccine Raw Materials Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 KACTUS Main Business Overview
11.16.5 KACTUS Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. mRNA Vaccine Raw Materials Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. mRNA Vaccine Raw Materials Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Plasmid DNA (pDNA)
Table 4. Major Players of Enzyme
Table 5. Major Players of Other
Table 6. mRNA Vaccine Raw Materials Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global mRNA Vaccine Raw Materials Market Size by Type (2021-2026) & ($ millions)
Table 8. Global mRNA Vaccine Raw Materials Market Size Market Share by Type (2021-2026)
Table 9. mRNA Vaccine Raw Materials Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global mRNA Vaccine Raw Materials Market Size by Application (2021-2026) & ($ millions)
Table 11. Global mRNA Vaccine Raw Materials Market Size Market Share by Application (2021-2026)
Table 12. Global mRNA Vaccine Raw Materials Revenue by Player (2021-2026) & ($ millions)
Table 13. Global mRNA Vaccine Raw Materials Revenue Market Share by Player (2021-2026)
Table 14. mRNA Vaccine Raw Materials Key Players Head office and Products Offered
Table 15. mRNA Vaccine Raw Materials Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global mRNA Vaccine Raw Materials Market Size by Region (2021-2026) & ($ millions)
Table 19. Global mRNA Vaccine Raw Materials Market Size Market Share by Region (2021-2026)
Table 20. Global mRNA Vaccine Raw Materials Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global mRNA Vaccine Raw Materials Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas mRNA Vaccine Raw Materials Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas mRNA Vaccine Raw Materials Market Size Market Share by Country (2021-2026)
Table 24. Americas mRNA Vaccine Raw Materials Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas mRNA Vaccine Raw Materials Market Size Market Share by Type (2021-2026)
Table 26. Americas mRNA Vaccine Raw Materials Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas mRNA Vaccine Raw Materials Market Size Market Share by Application (2021-2026)
Table 28. APAC mRNA Vaccine Raw Materials Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC mRNA Vaccine Raw Materials Market Size Market Share by Region (2021-2026)
Table 30. APAC mRNA Vaccine Raw Materials Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC mRNA Vaccine Raw Materials Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe mRNA Vaccine Raw Materials Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe mRNA Vaccine Raw Materials Market Size Market Share by Country (2021-2026)
Table 34. Europe mRNA Vaccine Raw Materials Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe mRNA Vaccine Raw Materials Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa mRNA Vaccine Raw Materials Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa mRNA Vaccine Raw Materials Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa mRNA Vaccine Raw Materials Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of mRNA Vaccine Raw Materials
Table 40. Key Market Challenges & Risks of mRNA Vaccine Raw Materials
Table 41. Key Industry Trends of mRNA Vaccine Raw Materials
Table 42. Global mRNA Vaccine Raw Materials Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global mRNA Vaccine Raw Materials Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global mRNA Vaccine Raw Materials Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global mRNA Vaccine Raw Materials Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Thermo Fisher Scientific Inc. Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 47. Thermo Fisher Scientific Inc. mRNA Vaccine Raw Materials Product Offered
Table 48. Thermo Fisher Scientific Inc. mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Thermo Fisher Scientific Inc. Main Business
Table 50. Thermo Fisher Scientific Inc. Latest Developments
Table 51. Danaher Corporation Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 52. Danaher Corporation mRNA Vaccine Raw Materials Product Offered
Table 53. Danaher Corporation mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Danaher Corporation Main Business
Table 55. Danaher Corporation Latest Developments
Table 56. Kaneka Eurogentec S.A. Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 57. Kaneka Eurogentec S.A. mRNA Vaccine Raw Materials Product Offered
Table 58. Kaneka Eurogentec S.A. mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Kaneka Eurogentec S.A. Main Business
Table 60. Kaneka Eurogentec S.A. Latest Developments
Table 61. BioSpring Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 62. BioSpring mRNA Vaccine Raw Materials Product Offered
Table 63. BioSpring mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. BioSpring Main Business
Table 65. BioSpring Latest Developments
Table 66. GenScript Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 67. GenScript mRNA Vaccine Raw Materials Product Offered
Table 68. GenScript mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. GenScript Main Business
Table 70. GenScript Latest Developments
Table 71. Aji Bio-Pharma Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 72. Aji Bio-Pharma mRNA Vaccine Raw Materials Product Offered
Table 73. Aji Bio-Pharma mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Aji Bio-Pharma Main Business
Table 75. Aji Bio-Pharma Latest Developments
Table 76. Merck KGaA Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 77. Merck KGaA mRNA Vaccine Raw Materials Product Offered
Table 78. Merck KGaA mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Merck KGaA Main Business
Table 80. Merck KGaA Latest Developments
Table 81. Aldevron Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 82. Aldevron mRNA Vaccine Raw Materials Product Offered
Table 83. Aldevron mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Aldevron Main Business
Table 85. Aldevron Latest Developments
Table 86. Hongene Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 87. Hongene mRNA Vaccine Raw Materials Product Offered
Table 88. Hongene mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Hongene Main Business
Table 90. Hongene Latest Developments
Table 91. WuXi Biologics Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 92. WuXi Biologics mRNA Vaccine Raw Materials Product Offered
Table 93. WuXi Biologics mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. WuXi Biologics Main Business
Table 95. WuXi Biologics Latest Developments
Table 96. Asymchem Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 97. Asymchem mRNA Vaccine Raw Materials Product Offered
Table 98. Asymchem mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Asymchem Main Business
Table 100. Asymchem Latest Developments
Table 101. Cosychem Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 102. Cosychem mRNA Vaccine Raw Materials Product Offered
Table 103. Cosychem mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Cosychem Main Business
Table 105. Cosychem Latest Developments
Table 106. Novoprotein Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 107. Novoprotein mRNA Vaccine Raw Materials Product Offered
Table 108. Novoprotein mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Novoprotein Main Business
Table 110. Novoprotein Latest Developments
Table 111. Vazyme Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 112. Vazyme mRNA Vaccine Raw Materials Product Offered
Table 113. Vazyme mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Vazyme Main Business
Table 115. Vazyme Latest Developments
Table 116. Yeasen Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 117. Yeasen mRNA Vaccine Raw Materials Product Offered
Table 118. Yeasen mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Yeasen Main Business
Table 120. Yeasen Latest Developments
Table 121. KACTUS Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 122. KACTUS mRNA Vaccine Raw Materials Product Offered
Table 123. KACTUS mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. KACTUS Main Business
Table 125. KACTUS Latest Developments
Table 1. mRNA Vaccine Raw Materials Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. mRNA Vaccine Raw Materials Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Plasmid DNA (pDNA)
Table 4. Major Players of Enzyme
Table 5. Major Players of Other
Table 6. mRNA Vaccine Raw Materials Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global mRNA Vaccine Raw Materials Market Size by Type (2021-2026) & ($ millions)
Table 8. Global mRNA Vaccine Raw Materials Market Size Market Share by Type (2021-2026)
Table 9. mRNA Vaccine Raw Materials Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global mRNA Vaccine Raw Materials Market Size by Application (2021-2026) & ($ millions)
Table 11. Global mRNA Vaccine Raw Materials Market Size Market Share by Application (2021-2026)
Table 12. Global mRNA Vaccine Raw Materials Revenue by Player (2021-2026) & ($ millions)
Table 13. Global mRNA Vaccine Raw Materials Revenue Market Share by Player (2021-2026)
Table 14. mRNA Vaccine Raw Materials Key Players Head office and Products Offered
Table 15. mRNA Vaccine Raw Materials Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global mRNA Vaccine Raw Materials Market Size by Region (2021-2026) & ($ millions)
Table 19. Global mRNA Vaccine Raw Materials Market Size Market Share by Region (2021-2026)
Table 20. Global mRNA Vaccine Raw Materials Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global mRNA Vaccine Raw Materials Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas mRNA Vaccine Raw Materials Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas mRNA Vaccine Raw Materials Market Size Market Share by Country (2021-2026)
Table 24. Americas mRNA Vaccine Raw Materials Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas mRNA Vaccine Raw Materials Market Size Market Share by Type (2021-2026)
Table 26. Americas mRNA Vaccine Raw Materials Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas mRNA Vaccine Raw Materials Market Size Market Share by Application (2021-2026)
Table 28. APAC mRNA Vaccine Raw Materials Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC mRNA Vaccine Raw Materials Market Size Market Share by Region (2021-2026)
Table 30. APAC mRNA Vaccine Raw Materials Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC mRNA Vaccine Raw Materials Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe mRNA Vaccine Raw Materials Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe mRNA Vaccine Raw Materials Market Size Market Share by Country (2021-2026)
Table 34. Europe mRNA Vaccine Raw Materials Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe mRNA Vaccine Raw Materials Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa mRNA Vaccine Raw Materials Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa mRNA Vaccine Raw Materials Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa mRNA Vaccine Raw Materials Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of mRNA Vaccine Raw Materials
Table 40. Key Market Challenges & Risks of mRNA Vaccine Raw Materials
Table 41. Key Industry Trends of mRNA Vaccine Raw Materials
Table 42. Global mRNA Vaccine Raw Materials Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global mRNA Vaccine Raw Materials Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global mRNA Vaccine Raw Materials Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global mRNA Vaccine Raw Materials Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Thermo Fisher Scientific Inc. Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 47. Thermo Fisher Scientific Inc. mRNA Vaccine Raw Materials Product Offered
Table 48. Thermo Fisher Scientific Inc. mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Thermo Fisher Scientific Inc. Main Business
Table 50. Thermo Fisher Scientific Inc. Latest Developments
Table 51. Danaher Corporation Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 52. Danaher Corporation mRNA Vaccine Raw Materials Product Offered
Table 53. Danaher Corporation mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Danaher Corporation Main Business
Table 55. Danaher Corporation Latest Developments
Table 56. Kaneka Eurogentec S.A. Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 57. Kaneka Eurogentec S.A. mRNA Vaccine Raw Materials Product Offered
Table 58. Kaneka Eurogentec S.A. mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Kaneka Eurogentec S.A. Main Business
Table 60. Kaneka Eurogentec S.A. Latest Developments
Table 61. BioSpring Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 62. BioSpring mRNA Vaccine Raw Materials Product Offered
Table 63. BioSpring mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. BioSpring Main Business
Table 65. BioSpring Latest Developments
Table 66. GenScript Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 67. GenScript mRNA Vaccine Raw Materials Product Offered
Table 68. GenScript mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. GenScript Main Business
Table 70. GenScript Latest Developments
Table 71. Aji Bio-Pharma Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 72. Aji Bio-Pharma mRNA Vaccine Raw Materials Product Offered
Table 73. Aji Bio-Pharma mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Aji Bio-Pharma Main Business
Table 75. Aji Bio-Pharma Latest Developments
Table 76. Merck KGaA Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 77. Merck KGaA mRNA Vaccine Raw Materials Product Offered
Table 78. Merck KGaA mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Merck KGaA Main Business
Table 80. Merck KGaA Latest Developments
Table 81. Aldevron Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 82. Aldevron mRNA Vaccine Raw Materials Product Offered
Table 83. Aldevron mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Aldevron Main Business
Table 85. Aldevron Latest Developments
Table 86. Hongene Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 87. Hongene mRNA Vaccine Raw Materials Product Offered
Table 88. Hongene mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Hongene Main Business
Table 90. Hongene Latest Developments
Table 91. WuXi Biologics Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 92. WuXi Biologics mRNA Vaccine Raw Materials Product Offered
Table 93. WuXi Biologics mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. WuXi Biologics Main Business
Table 95. WuXi Biologics Latest Developments
Table 96. Asymchem Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 97. Asymchem mRNA Vaccine Raw Materials Product Offered
Table 98. Asymchem mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Asymchem Main Business
Table 100. Asymchem Latest Developments
Table 101. Cosychem Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 102. Cosychem mRNA Vaccine Raw Materials Product Offered
Table 103. Cosychem mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Cosychem Main Business
Table 105. Cosychem Latest Developments
Table 106. Novoprotein Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 107. Novoprotein mRNA Vaccine Raw Materials Product Offered
Table 108. Novoprotein mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Novoprotein Main Business
Table 110. Novoprotein Latest Developments
Table 111. Vazyme Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 112. Vazyme mRNA Vaccine Raw Materials Product Offered
Table 113. Vazyme mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Vazyme Main Business
Table 115. Vazyme Latest Developments
Table 116. Yeasen Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 117. Yeasen mRNA Vaccine Raw Materials Product Offered
Table 118. Yeasen mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Yeasen Main Business
Table 120. Yeasen Latest Developments
Table 121. KACTUS Details, Company Type, mRNA Vaccine Raw Materials Area Served and Its Competitors
Table 122. KACTUS mRNA Vaccine Raw Materials Product Offered
Table 123. KACTUS mRNA Vaccine Raw Materials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. KACTUS Main Business
Table 125. KACTUS Latest Developments
LIST OF FIGURES
Figure 1. mRNA Vaccine Raw Materials Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global mRNA Vaccine Raw Materials Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. mRNA Vaccine Raw Materials Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. mRNA Vaccine Raw Materials Sales Market Share by Country/Region (2025)
Figure 8. mRNA Vaccine Raw Materials Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global mRNA Vaccine Raw Materials Market Size Market Share by Type in 2025
Figure 10. mRNA Vaccine Raw Materials in (non-replicating) mRNA vaccine
Figure 11. Global mRNA Vaccine Raw Materials Market: (non-replicating) mRNA vaccine (2021-2026) & ($ millions)
Figure 12. mRNA Vaccine Raw Materials in (self-amplifying) mRNA vaccine
Figure 13. Global mRNA Vaccine Raw Materials Market: (self-amplifying) mRNA vaccine (2021-2026) & ($ millions)
Figure 14. Global mRNA Vaccine Raw Materials Market Size Market Share by Application in 2025
Figure 15. Global mRNA Vaccine Raw Materials Revenue Market Share by Player in 2025
Figure 16. Global mRNA Vaccine Raw Materials Market Size Market Share by Region (2021-2026)
Figure 17. Americas mRNA Vaccine Raw Materials Market Size 2021-2026 ($ millions)
Figure 18. APAC mRNA Vaccine Raw Materials Market Size 2021-2026 ($ millions)
Figure 19. Europe mRNA Vaccine Raw Materials Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa mRNA Vaccine Raw Materials Market Size 2021-2026 ($ millions)
Figure 21. Americas mRNA Vaccine Raw Materials Value Market Share by Country in 2025
Figure 22. United States mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC mRNA Vaccine Raw Materials Market Size Market Share by Region in 2025
Figure 27. APAC mRNA Vaccine Raw Materials Market Size Market Share by Type (2021-2026)
Figure 28. APAC mRNA Vaccine Raw Materials Market Size Market Share by Application (2021-2026)
Figure 29. China mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 33. India mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe mRNA Vaccine Raw Materials Market Size Market Share by Country in 2025
Figure 36. Europe mRNA Vaccine Raw Materials Market Size Market Share by Type (2021-2026)
Figure 37. Europe mRNA Vaccine Raw Materials Market Size Market Share by Application (2021-2026)
Figure 38. Germany mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 39. France mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 40. UK mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa mRNA Vaccine Raw Materials Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa mRNA Vaccine Raw Materials Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa mRNA Vaccine Raw Materials Market Size Market Share by Application (2021-2026)
Figure 46. Egypt mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 52. APAC mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 53. Europe mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 55. United States mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 56. Canada mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 57. Mexico mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 58. Brazil mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 59. China mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 60. Japan mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 61. Korea mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 63. India mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 64. Australia mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 65. Germany mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 66. France mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 67. UK mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 68. Italy mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 69. Russia mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 70. Egypt mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 71. South Africa mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 72. Israel mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 73. Turkey mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 74. Global mRNA Vaccine Raw Materials Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global mRNA Vaccine Raw Materials Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 1. mRNA Vaccine Raw Materials Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global mRNA Vaccine Raw Materials Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. mRNA Vaccine Raw Materials Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. mRNA Vaccine Raw Materials Sales Market Share by Country/Region (2025)
Figure 8. mRNA Vaccine Raw Materials Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global mRNA Vaccine Raw Materials Market Size Market Share by Type in 2025
Figure 10. mRNA Vaccine Raw Materials in (non-replicating) mRNA vaccine
Figure 11. Global mRNA Vaccine Raw Materials Market: (non-replicating) mRNA vaccine (2021-2026) & ($ millions)
Figure 12. mRNA Vaccine Raw Materials in (self-amplifying) mRNA vaccine
Figure 13. Global mRNA Vaccine Raw Materials Market: (self-amplifying) mRNA vaccine (2021-2026) & ($ millions)
Figure 14. Global mRNA Vaccine Raw Materials Market Size Market Share by Application in 2025
Figure 15. Global mRNA Vaccine Raw Materials Revenue Market Share by Player in 2025
Figure 16. Global mRNA Vaccine Raw Materials Market Size Market Share by Region (2021-2026)
Figure 17. Americas mRNA Vaccine Raw Materials Market Size 2021-2026 ($ millions)
Figure 18. APAC mRNA Vaccine Raw Materials Market Size 2021-2026 ($ millions)
Figure 19. Europe mRNA Vaccine Raw Materials Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa mRNA Vaccine Raw Materials Market Size 2021-2026 ($ millions)
Figure 21. Americas mRNA Vaccine Raw Materials Value Market Share by Country in 2025
Figure 22. United States mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC mRNA Vaccine Raw Materials Market Size Market Share by Region in 2025
Figure 27. APAC mRNA Vaccine Raw Materials Market Size Market Share by Type (2021-2026)
Figure 28. APAC mRNA Vaccine Raw Materials Market Size Market Share by Application (2021-2026)
Figure 29. China mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 33. India mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe mRNA Vaccine Raw Materials Market Size Market Share by Country in 2025
Figure 36. Europe mRNA Vaccine Raw Materials Market Size Market Share by Type (2021-2026)
Figure 37. Europe mRNA Vaccine Raw Materials Market Size Market Share by Application (2021-2026)
Figure 38. Germany mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 39. France mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 40. UK mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa mRNA Vaccine Raw Materials Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa mRNA Vaccine Raw Materials Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa mRNA Vaccine Raw Materials Market Size Market Share by Application (2021-2026)
Figure 46. Egypt mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries mRNA Vaccine Raw Materials Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 52. APAC mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 53. Europe mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 55. United States mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 56. Canada mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 57. Mexico mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 58. Brazil mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 59. China mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 60. Japan mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 61. Korea mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 63. India mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 64. Australia mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 65. Germany mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 66. France mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 67. UK mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 68. Italy mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 69. Russia mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 70. Egypt mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 71. South Africa mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 72. Israel mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 73. Turkey mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
Figure 74. Global mRNA Vaccine Raw Materials Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global mRNA Vaccine Raw Materials Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries mRNA Vaccine Raw Materials Market Size 2027-2032 ($ millions)
